Octreotide treatment for sulfonylurea-induced hypoglycaemia

Peter C Veitch,* Rory J Clifton-Bligh†

1 Department of Aged Care and Rehabilitation Medicine
2 Department of Endocrinology, Royal North Shore Hospital, Clinic 1, Level 3, Pacific Highway, St Leonards, NSW 2065.

Correspondence: rclifton@med.usyd.edu.au

1. Veitch PC, Clifton-Bligh RJ. Long-acting sulfonylureas — long acting hypoglycaemia. Med J Aust 2004; 180: 84-85. <eMJA full text>
2. McLaughlin SA, Crandall CS, McKinney PE. Octreotide: an antidote for sulfonylurea-induced hypoglycaemia. Ann Emerg Med 2000; 36: 133-138.

Online responses are no longer available. Please refer to our instructions for authors page for more information.